GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rang in aandelen
#3658
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aandeelprijs
$27.24
Marktkapitalisatie
$4.61B
Verandering (1 dag)
-1.10%
Verandering (1 jaar)
-13.10%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Categorie
Healthcare
Dividendrendementgeschiedenis voor GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Het dividendrendement (TTM) van GlaxoSmithKline Pharmaceuticals Limited (aandelsymbool: GLAXO) per 2024-03-31 is: 1.61%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 2.91%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 2.91%
Dividendrendementgeschiedenis van GlaxoSmithKline Pharmaceuticals Limited (GLAXO) van 2004 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
| Jaar | Dividendrendement | Wijzigen |
|---|---|---|
| 2026 (TTM) | 2.28% | 44.30% |
| 2025 | 1.58% | -1.86% |
| 2024 | 1.61% | -76.32% |
| 2023 | 6.80% | 279.89% |
| 2022 | 1.79% | -35.38% |
| 2021 | 2.77% | 44.27% |
| 2020 | 1.92% | 42.22% |
| 2019 | 1.35% | -5.59% |
| 2018 | 1.43% | -21.43% |
| 2017 | 1.82% | 10.98% |
| 2016 | 1.64% | 40.17% |
| 2015 | 1.17% | -29.52% |
| 2013 | 1.66% | -19.42% |
| 2012 | 2.06% | 0.49% |
| 2011 | 2.05% | 60.16% |
| 2010 | 1.28% | -48.18% |
| 2009 | 2.47% | -20.58% |
| 2008 | 3.11% | 3.67% |
| 2007 | 3.00% | 25.00% |
| 2006 | 2.40% | 10.60% |
| 2005 | 2.17% | 65.65% |
| 2004 | 1.31% | 0.00% |
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
| Bedrijf | Dividendrendement | Land |
|---|---|---|
| 0.55% |
US
|
|
| 2.08% |
US
|
|
| 2.44% |
US
|
|
| 2.31% |
US
|
|
| 2.69% |
CH
|
